98

Jenscare Scientific Co LtdHKG 9877 Stock Report

Last reporting period 31 Dec, 2022

Updated 19 Sep, 2024

Last price

Market cap $B

1.512

Small

Exchange

XHKG - Hong Kong Exchange

9877.HK Stock Analysis

98

Uncovered

Jenscare Scientific Co Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

1.512

Dividend yield

Shares outstanding

417.17 B

Jenscare Scientific Co., Ltd. is a holding company, which develops and sells transcatheter aortic valve systems. The company is headquartered in Ningbo, Zhejiang. The company went IPO on 2022-10-10. The firm develops interventional products for the treatment of structural heart disease. The firm's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The firm also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. The firm mainly conducts its businesses in the domestic market.

View Section: Eyestock Rating